Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Parkinson's Disease”

225 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 225 results

Not applicableStudy completedNCT04048265
What this trial is testing

TMS Treatment in Parkinson's Disease With Pain.

Who this might be right for
Transcranial Magnetic StimulationParkinson DiseasePain
Xuanwu Hospital, Beijing 52
Post-approval studies (Phase 4)Study completedNCT00153972
What this trial is testing

Dopamine Turnover Rate as Surrogate Parameter for Diagnosis of Early Parkinson's Disease

Who this might be right for
Parkinson's Disease
Technische Universität Dresden 39
Testing effectiveness (Phase 2)UnknownNCT03242499
What this trial is testing

Lovastatin as a Neuroprotective Treatment for Early Stage Parkinson's Disease

Who this might be right for
Parkinson Disease
National Taiwan University Hospital 80
Testing effectiveness (Phase 2)Study completedNCT04928287
What this trial is testing

Randomized, Double-Blind Clinical Trial for Parkinson's Disease (Early and Moderate)

Who this might be right for
Parkinson Disease
Hope Biosciences Research Foundation 24
Not applicableStudy completedNCT02627664
What this trial is testing

Study of Dysarthria, Swallowing Disorders and Respiratory in Parkinson's Disease

Who this might be right for
Parkinson's Disease
University Hospital, Lille 70
Early research (Phase 1)Study completedNCT02728947
What this trial is testing

Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's Disease

Who this might be right for
Parkinson's Disease
Luye Pharma Group Ltd. 28
Not applicableLooking for participantsNCT05286736
What this trial is testing

Neuroplasticity in Parkinson's Disease

Who this might be right for
ParkinsonParkinson Disease
University of Minnesota 50
Testing effectiveness (Phase 2)UnknownNCT04305002
What this trial is testing

Exenatide Treatment in Parkinson's Disease

Who this might be right for
Parkinson Disease
Center for Neurology, Stockholm 60
Testing effectiveness (Phase 2)Looking for participantsNCT07166757
What this trial is testing

Clinical Study to Evaluate XS411 in Treatment of Early-onset Parkinson's Disease

Who this might be right for
Parkinson Disease (PD)
XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. 90
Not applicableLooking for participantsNCT07533799
What this trial is testing

The Swedish BioFINDER Sleep Study

Who this might be right for
Parkinson´s DiseaseREM Sleep Behavior Disorder (iRBD)Lewy Body Disease+2 more
Skane University Hospital 650
Not applicableStudy completedNCT05967598
What this trial is testing

Effect of taVNS of Brainstem Activation in Early and Late Parkinson's Disease Patients - an fMRI Study

Who this might be right for
Parkinson DiseaseNeurologic Disorder
University of Ljubljana 40
Testing effectiveness (Phase 2)Looking for participantsNCT06680830
What this trial is testing

Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

Who this might be right for
Parkinson DiseaseParkinsonIdiopathic Parkinson Disease+2 more
Neuron23 Inc. 150
Not applicableLooking for participantsNCT02760108
What this trial is testing

Parkinson's Families Project

Who this might be right for
Parkinson's DiseaseParkinsonism
University College, London 2,000
Large-scale testing (Phase 3)Study completedNCT00474058
What this trial is testing

Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine

Who this might be right for
Parkinson's Disease
UCB Pharma 287
Early research (Phase 1)UnknownNCT02579473
What this trial is testing

Weekly Subcutaneous Injections of SER-214 in Subjects With Parkinson's Disease (PD), to Determine the Safety, Tolerability and Pharmacokinetic (PK) Profile of SER-214

Who this might be right for
Parkinson's Disease
Serina Therapeutics 20
Post-approval studies (Phase 4)Study completedNCT00321854
What this trial is testing

Study of (Mirapex) Pramipexole for the Early Treatment of Parkinsons Disease (PD)

Who this might be right for
Parkinson Disease
Boehringer Ingelheim 535
Not applicableEnded earlyNCT01701128
What this trial is testing

The Effect of Exercise Training on Gait and Quality of Life in Parkinson's Disease

Who this might be right for
Parkinson's Disease
Laval University 35
Not applicableLooking for participantsNCT06232772
What this trial is testing

Research on Novel Biomarkers for Early Diagnosis of Parkinson's Disease:An Observational, Multicenter, Non-Randomized Controlled Study

Who this might be right for
Parkinson's Disease
Yousheng Xiao 600
Not applicableLooking for participantsNCT06916507
What this trial is testing

Study to Assess Real Life Effectiveness of Foslevodopa/Foscarbidopa in Adult German Participants at Initial Stages of Advanced Parkinson's Disease (EARLY-FOS)

Who this might be right for
Parkinson's Disease
AbbVie 125
Not applicableWithdrawnNCT04536857
What this trial is testing

Detection of A-synuclein Aggregate as Biomarker in Diagnosing Parkinson's Disease at Early Stage by Using Protein Misfolding Cyclic Amplification (PMCA)

Who this might be right for
Parkinson's Disease
Huashan Hospital
Load More Results